A study of prospective surveillance for inhibitors among persons with haemophilia in the united states

J. M. Soucie,Connie H. Miller,Fiona M. Kelly,Amanda B. Payne,Melissa S. Creary,Paula L. Bockenstedt,Christine L. Kempton,Marilyn J. Manco-Johnson,Anne T. Neff,Thomas C. Abshire,Doreen B. Brettler,Jorge Di Paola,Steven R. Lentz,Mohamed Radhi,Gita Massey,John C. Barrett,Amy D. Shapiro,Michael D. Tarantino,Brian M. Wicklund,Christine M. Knoll,Miguel A. Escobar,M. Elaine Eyster,Joan Cox Gill,Cindy Leissinger,Hassan M. Yaish

A study of prospective surveillance for inhibitors among persons with haemophilia in the united states

2014

Introduction Inhibitors are a rare but serious complication of treatment of patients with haemophilia. Phase III clinical trials enroll too few patients to adequately assess new product inhibitor risk.

Keywords:

Physical therapy
Prospective cohort study
Surgery
Public health surveillance
Young adult
Phases of clinical research
Haemophilia
Medicine
Complication
Factor IX
Pediatrics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations